SoftBank’s second Vision Fund has led a new US$165 million funding round in California-based Karius, which markets a test that can quickly detect hard to diagnose infections through a simple taking of blood, the start-up said on Monday.
SoftBank leads US$165 million capital boost for liquid biopsy firm Karius
